Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R M Bukowski

Showing results (101-110 of 167) with videos related to

Pageof 17
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 11, 1992
Phase II trial of chlorozotocin and fluorouracil in islet cell carcinoma: a Southwest Oncology Group studyR M Bukowski, C Tangen, R Lee, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|November 1, 1994
Amifostine: potential for clinically useful cytoprotectionG T Budd, V Lorenzi, R Ganapathi, et al.
Biochemical Pharmacology|January 4, 2001
Cell cycle phase specificity in the potentiation of etoposide-induced DNA damage and apoptosis by KN-62, an inhibitor of calcium-calmodulin-dependent enzymesM Aoyama, D R Grabowski, K A Holmes, et al.
Cell Growth & Differentiation : the Molecular Biology Journal of the American Association for Cancer Research|July 1, 1996
Resistance to interleukin 6 in human non-small cell lung carcinoma cell lines: role of receptor componentsM K Ganapathi, A K Weizer, S Borsellino, et al.
Cancer Treatment Reports|May 1, 1987
Evaluation of fludarabine phosphate in renal cell carcinoma: a Southwest Oncology Group StudyL Balducci, B Blumenstein, D D Von Hoff, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1993
Phase II trial of mitotane and cisplatin in patients with adrenal carcinoma: a Southwest Oncology Group studyR M Bukowski, M Wolfe, H S Levine, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|December 31, 1997
Defective granzyme B gene expression and lytic response in T lymphocytes infiltrating human renal cell carcinomaS Kudoh, C Redovan, P Rayman, et al.
Cancer Treatment Reports|March 1, 1981
Simultaneous treatment with cisplatin and radiation therapy for advanced solid tumors: a pilot studyR R Reimer, R Gahbauer, R M Bukowski, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 13, 2001
Tumor-induced sensitivity to apoptosis in T cells from patients with renal cell carcinoma: role of nuclear factor-kappaB suppressionJ H Finke, P Rayman, R George, et al.
Journal of Cancer Research and Clinical Oncology|May 18, 2001
Phase I and II trials of subcutaneously administered rIL-2, interferon alfa-2a, and fluorouracil in patients with metastatic renal carcinomaT Olencki, D Peereboom, L Wood, et al.
Pageof 17

Showing results (101-110 of 167) with videos related to

Sort By:
Pageof 17
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 11, 1992
Phase II trial of chlorozotocin and fluorouracil in islet cell carcinoma: a Southwest Oncology Group studyR M Bukowski, C Tangen, R Lee, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|November 1, 1994
Amifostine: potential for clinically useful cytoprotectionG T Budd, V Lorenzi, R Ganapathi, et al.
Biochemical Pharmacology|January 4, 2001
Cell cycle phase specificity in the potentiation of etoposide-induced DNA damage and apoptosis by KN-62, an inhibitor of calcium-calmodulin-dependent enzymesM Aoyama, D R Grabowski, K A Holmes, et al.
Cell Growth & Differentiation : the Molecular Biology Journal of the American Association for Cancer Research|July 1, 1996
Resistance to interleukin 6 in human non-small cell lung carcinoma cell lines: role of receptor componentsM K Ganapathi, A K Weizer, S Borsellino, et al.
Cancer Treatment Reports|May 1, 1987
Evaluation of fludarabine phosphate in renal cell carcinoma: a Southwest Oncology Group StudyL Balducci, B Blumenstein, D D Von Hoff, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1993
Phase II trial of mitotane and cisplatin in patients with adrenal carcinoma: a Southwest Oncology Group studyR M Bukowski, M Wolfe, H S Levine, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|December 31, 1997
Defective granzyme B gene expression and lytic response in T lymphocytes infiltrating human renal cell carcinomaS Kudoh, C Redovan, P Rayman, et al.
Cancer Treatment Reports|March 1, 1981
Simultaneous treatment with cisplatin and radiation therapy for advanced solid tumors: a pilot studyR R Reimer, R Gahbauer, R M Bukowski, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 13, 2001
Tumor-induced sensitivity to apoptosis in T cells from patients with renal cell carcinoma: role of nuclear factor-kappaB suppressionJ H Finke, P Rayman, R George, et al.
Journal of Cancer Research and Clinical Oncology|May 18, 2001
Phase I and II trials of subcutaneously administered rIL-2, interferon alfa-2a, and fluorouracil in patients with metastatic renal carcinomaT Olencki, D Peereboom, L Wood, et al.
Pageof 17